Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Limited cross-border infections in patients newly diagnosed with HIV in Europe.
Update of the drug resistance mutations in HIV-1: March 2013.
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure.
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort.
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.
Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.